GENOPIS Trademark

Trademark Overview


On Friday, September 21, 2018, a trademark application was filed for GENOPIS with the United States Patent and Trademark Office. The USPTO has given the GENOPIS trademark a serial number of 88126908. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, February 10, 2021. This trademark is owned by ViroMed Co., Ltd.. The GENOPIS trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

(Based on Intent to Use) pharmaceutical and veterinary preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical purposes; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for ...

(Based on Intent to Use and Section 44(d)) Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents

(Based on Intent to Use and Section 44(d)) Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical res...
genopis

General Information


Serial Number88126908
Word MarkGENOPIS
Filing DateFriday, September 21, 2018
Status601 - ABANDONED - EXPRESS
Status DateWednesday, February 10, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on Intent to Use) pharmaceutical and veterinary preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical purposes; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in veterinary genetic testing for medical use
Goods and Services(Based on Intent to Use and Section 44(d)) Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents
Goods and Services(Based on Intent to Use and Section 44(d)) Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 27, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 27, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHELIXMITH CO., LTD
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSEOUL 08826
KR

Party NameViroMed Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 08826
KR

Trademark Events


Event DateEvent Description
Wednesday, February 10, 2021ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Wednesday, February 10, 2021ABANDONMENT - EXPRESS MAILED
Tuesday, February 9, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Monday, February 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 3, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 22, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 1, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 1, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, September 26, 2019ASSIGNED TO LIE
Wednesday, June 19, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 7, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2019SUSPENSION LETTER WRITTEN
Tuesday, March 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION WRITTEN
Saturday, January 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION WRITTEN
Saturday, January 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION E-MAILED
Saturday, January 5, 2019NON-FINAL ACTION WRITTEN
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Thursday, September 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 25, 2018NEW APPLICATION ENTERED IN TRAM